Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study

Abstract Background A retrospective case-control study was performed to evaluate whether PCOS-specific serum markers would change in women with polycystic ovary syndrome (PCOS) during the course of two consecutive cycles of clomiphene citrate (CC)-stimulation, which did not lead to a pregnancy. Meth...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Marlene Hager (Autore), Steffen Hörath (Autore), Peter Frigo (Autore), Marianne Koch (Autore), Rodrig Marculescu (Autore), Johannes Ott (Autore)
Natura: Libro
Pubblicazione: BMC, 2019-10-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_55831d14dacb45ebb90440b9fbc9b11d
042 |a dc 
100 1 0 |a Marlene Hager  |e author 
700 1 0 |a Steffen Hörath  |e author 
700 1 0 |a Peter Frigo  |e author 
700 1 0 |a Marianne Koch  |e author 
700 1 0 |a Rodrig Marculescu  |e author 
700 1 0 |a Johannes Ott  |e author 
245 0 0 |a Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study 
260 |b BMC,   |c 2019-10-01T00:00:00Z. 
500 |a 10.1186/s13048-019-0564-7 
500 |a 1757-2215 
520 |a Abstract Background A retrospective case-control study was performed to evaluate whether PCOS-specific serum markers would change in women with polycystic ovary syndrome (PCOS) during the course of two consecutive cycles of clomiphene citrate (CC)-stimulation, which did not lead to a pregnancy. Methods Anovulatory PCOS patients who underwent two consecutive CC-cycles (n = 41) and anovulatory PCOS controls who chose an observational approach for two months (n = 24) were included in the study. The main outcome measures were levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), anti-Mullerian hormone (AMH), total testosterone, androstenedione, and sexual hormone binding globulin (SHBG). Results In the control group, PCOS-specific serum parameters did not change during two months (p > 0.05). In the CC-group, there were decreases in LH (11.8 ± 4.9 mU/mL vs. 10.9 ± 4.0 mU/mL; p = 0.029), the LH:FSH ratio (2.1 ± 0.8 mU/mL vs. 1.8 ± 0.5 mU/mL; p = 0.007), and AMH (8.08 ± 4.27 ng/mL vs. 7.17 ± 3.37 ng/mL; p = 0.011), as well as an increase in SHBG (46.0 ± 20.2 nmol/L vs. 51.2 ± 21.0 nmol/L; p < 0.001). A higher age and lower baseline total testosterone and AMH levels were predictive of an AMH decline (p < 0.05). Conclusion Two cycles of CC-stimulation that did not lead to a pregnancy were accompanied by mean LH, AMH, and LH:FSH ratio declines and an SHBG increase. The clinical significance seems of minor relevance. 
546 |a EN 
690 |a Polycystic ovary syndrome 
690 |a Androgens 
690 |a Ovarian stimulation 
690 |a Clomiphene 
690 |a Ovarian reserve 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Journal of Ovarian Research, Vol 12, Iss 1, Pp 1-6 (2019) 
787 0 |n http://link.springer.com/article/10.1186/s13048-019-0564-7 
787 0 |n https://doaj.org/toc/1757-2215 
856 4 1 |u https://doaj.org/article/55831d14dacb45ebb90440b9fbc9b11d  |z Connect to this object online.